Response Oncology, Inc. (ROIX) Research

Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year. Historically, the company functioned as a comprehensive cancer management firm, providing advanced cancer treatment through its outpatient IMPACT Centers, overseeing the non-medical aspects of oncology practices, compounding and dispensing pharmaceuticals to specific oncologists, and conducting outcomes research for pharmaceutical manufacturers.

Market snapshot

Symbol
ROIX
Price
$0.00
Day change
0.00%
Market cap
$12.0
52-week range
1.0E-6-1.0E-6
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • The Greenrose Holding Company Inc. (GNRS)
  • LifeHOUSE Holdings, LLC (LHRP)
  • QMed, Inc. (QMED)
  • Refocus Group, Inc. (RFCS)
  • Synvista Therapeutics, Inc. (SYNI)
  • VeriTeQ Corporation (VTEQ)

Open Response Oncology, Inc. (ROIX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.